Electronics for spatially distributed sensors and transducer arrays
Europe’s and indeed the world’s aging population with an ever longer life expectancy is causing a dramatic increase in the incidence of chronic diseases; at the age of 70 the occurrence of three or four concurrent medical conditions is now common for many of our citizens. A response by the medical technology sector to combat some of these conditions has been the development of active implantable medicals devices. The disperse project will enable disruption of the therapy market and break the dominance of large pharmaceutical companies by influencing the factors that challenge the strong growth of aimds.
current medical practice excludes patients with implants from access to magnetic resonance imaging (mri). Today with state-of-the-art implants scanning a patient with a single implant is only allowed under strict and limiting conditions thereby increasing the exam time by factors. Disperse will develop innovative electronic solutions to scan patients with multiple implants by a factor 3 reduction in exam time and improved accuracy compared to state-of-the-art in a clinical hospital setting
the results of disperse will fuel the forecasted double digit cagr for disperse aimds, leading to a total market size of b€ 6.9 in 2020. In the same year the mri market will have grown to b€ 6.1, supported by disperse through shorter examinations times and improved diagnostic capabilities. Technology developments from disperse also have large application potential in other markets, such as smart cities and space.
the innovative aspects of disperse include: 1) improved mr conditional implants; 2) multi-implant coexistence; 3) optimal mri workflow for implants; 4) new and improved components. Tangible results include, among others: aimds causing less mri distortion, new methods for multi-implant testing, sensor arrays with increased density, miniaturized, low power, sensor and actuator electronics (asics), high speed, low power and low volume photonic modules for data transmission.
in order to meet the key objectives, the consortium includes a clinical end user, application partners, and technology and knowledge providers working together on innovations in photonics, micro-electronic design and packaging. Disperse brings together the implant manufacturers cochlear, g-therapetics with the mri manufacturer philips and the clinical end user uz gastenhuisberg (ku leuven). The acoustic specialists sorama and sound intelligence will work together with the users philips and ku leuven, to develop new acoustic monitoring solutions for detecting patient anxiety which are feasible in the harsh acoustic environment of mri.
the project partners benefit from synergies with the space domain, in particular astronomy, with respect to knowledge on digitization and synchronized networks in in large distributed multiple sensors arrays. In turn, future arrays can be built with commercialized disperse components.